Dennis Podlesak

CIK 1314595 · last filed 2026-02-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.38M

Companies

4

Total Filings

34

Lifetime Open-Market Net

-$2.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SNDX Director 239,763 $18.25 $4.38M -$2.58M 16 2026-02-06
Tobira Therapeutics, Inc. (TBRA) Delisted Director $0 3 2016-01-14
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted Director 336,394 $0 8 2014-02-14
Tobira Therapeutics, Inc. (RGDO) Delisted Director $0 2 2014-01-03

Recent Filings · Page 2 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-14 SNDX Grant (A) $0 EDGAR
2019-06-12 SNDX Grant (A) $0 EDGAR
2019-05-07 Grant (A) +85,254 $0
2018-05-25 SNDX Grant (A) $0 EDGAR
2018-02-12 SNDX Grant (A) $0 EDGAR
2017-05-19 SNDX Grant (A) $0 EDGAR
2016-11-03 Disp (D) $0
2016-11-02 SNDX Grant (A) $0 EDGAR
2016-01-14 Tobira Therapeutics, Inc. (TBRA) Delisted Grant (A) $0 EDGAR
2015-07-13 Tobira Therapeutics, Inc. (TBRA) Delisted Grant (A) $0 EDGAR
Showing 1120 of 34
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.